Streptococcus pneumoniae News and Research

RSS

Streptococcus pneumoniae, or Pneumococcus, is a very common bacterial infection in both industrialized and developing countries. In particular, young children and the elderly represent high-risk populations of developing pneumococcal infections. According to the WHO, the bacterium kills up to one million children under the age of five years each year worldwide. It accounts for many Bacterial Meningitis cases in adults and it is the most common cause of Bacteraemia, Pneumonia, Meningitis and Otitis media in young children.

Strain of the bacteria Streptococcus pneumoniae that causes ear infections emerges; resistant to antibiotics, pneumococcal vaccine

A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.

17 Oct 2007

Research highlights importance of adopting current adult pneumococcal vaccination guidelines

Among patients hospitalized with community-acquired pneumonia, those who had previously received the pneumococcal vaccine had a lower risk of death and admission to the intensive care unit than patients who were not vaccinated, according to a report in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

9 Oct 2007

New understanding of what makes a major global bacterial infection deadly

Researchers believe they have discovered why a bacterial lung infection is so lethal in the early stages, and it's not what medical authorities had thought, according to research published in the journal Immunity.

28 Aug 2007

Meningococcal vaccine now recommended for ages 11 to 18

Recommendations by the Centers for Disease Control and Prevention, (CDC), that all young people aged 11 to 18 should get a shot that protects them from the most dangerous type of meningitis, has been applauded by the National Foundation for Infectious Diseases (NFID).

28 Jun 2007

Nasal spray of virus enzymes for ear infections

Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting severe middle ear infections, based on results of a study done in mice by investigators from St. Jude and The Rockefeller University.

27 Apr 2007

Increase in pneumococcal infections not covered by childhood vaccine

Alaskan native children are experiencing increased rates of serious infections caused by strains of pneumococcal bacteria that are not covered by the current childhood pneumococcal vaccine, indicating the importance of ongoing surveillance of vaccine effectiveness, according to a study in the current issue of JAMA.

25 Apr 2007

Viral protein is an effective preventative against infection

For parents, eight million cases of acute middle-ear infections every year adds up to a lot of sleepless nights and trips to the pediatrician.

25 Mar 2007

New method for identifying viruses and bacteria that cause common infections in children

Infectious disease specialists at UT Southwestern Medical Center have found a new method for identifying suspect viruses and bacteria that cause some of the most common acute infections in children.

13 Mar 2007

Children with chronic otitis media have biofilms in their middle ears

Direct evidence of bacterial biofilms has been found on the middle ear tissue of children who suffer from chronic ear infections

12 Jul 2006

Health experts meet in Asia to discuss preventing deadly childhood diseases

The deadly diseases pneumonia and meningitis kill an estimated 1.8 million children under the age of 5 years across the globe every year. Of these, more than 700,000 occur in the countries in the South-East Asia and Western Pacific regions of the World Health Organization (WHO).

30 Mar 2006

Vaccinated adults less likely to die from pneumonia

Adults hospitalized for pneumonia who have received the pneumococcal vaccine are at a lower risk of dying from the disease than those who haven't been vaccinated, according to an article in the April 15 issue of Clinical Infectious Diseases.

19 Mar 2006

FDA grants Cerexa fast track designation

Cerexa has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PPI-0903, a next-generation, broad-spectrum, cephalosporin antibiotic, for the treatment of complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA).

17 Mar 2006

New tools in the fight against pneumococci

New tools in the fight against pneumococci - the bugs targeted by vaccines recently announced by the Department of Health - are described by a team led by scientists from the Wellcome Trust Sanger Institute.

13 Mar 2006

Link between childhood exposure to tobacco smoke and Streptococcus pneumoniae

Many of the medical risks associated with smoking, such as cancer, emphysema and heart attacks, are well-known to physicians and the general public.

13 Mar 2006

New fungal defensin, plectasin, possesses as much power as penicillin

A peptide identified in a fungus found in northern European pine forests possesses as much power as penicillin as well as vancomycin, according to an international team of researchers.

12 Oct 2005

Fewer antibiotic prescriptions leads to fewer superbugs

That's the take-home message behind a new study in the Oct. 15 issue of Clinical Infectious Diseases, now available online. The study found that reducing antibiotic use for pediatric respiratory tract infections resulted in lower rates of carriage of drug-resistant bacteria.

6 Sep 2005

Specialized immune-system B cells play dual role in triggering both kinds of immunity - innate and acquired

A specialized subpopulation of the antibody-producing B cells of the immune system plays a "double-barreled" role in triggering both kinds of immunity - innate and acquired, Duke University Medical Center immunologists have discovered.

26 Jul 2005

Bacteria use host's immune response to their competitive advantage

Millions of bacteria live within the recesses of our noses and upper respiratory tracts, waiting for a chance to infiltrate and infect. But long before these bacteria break through our immune defenses, they must first compete against other bacterial species to colonize the mucus-lined surfaces of our noses.

24 Jul 2005

Alcohol consumption increases movement of S. pneumoniae toward the lungs

Streptococcus pneumoniae is a bacterium that can infect the upper respiratory tract and cause pneumonia, as well as infections in other parts of the body such as the bloodstream (bacteremia), lining of the brain and spinal cord (meningitis), bones (osteomyelitis), joints (arthritis), ears (otitis media) and sinuses (sinusitis).

15 May 2005

Scientists find how pneumonia bacteria get sugar boost to survive

Meningitis and pneumonia bacteria smash into our lungs and cells to steal sugar, which helps them survive, according to research presented from King's College and Guy's Hospital London, (Monday, 04 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.

4 Apr 2005